€3.22
1.10%
L&S, Jun 28, 10:54 pm CET
ISIN
CA94947L1022
Symbol
WELL

WELL Health Technologies Target price 2024 - Analyst rating & recommendation

WELL Health Technologies Classifications & Recommendation:

Buy
93%
Hold
7%

WELL Health Technologies Target price

Target price CAD7.60
Course CAD4.71
Price potential
Number of estimates 15
15 Analysts have issued a price target WELL Health Technologies 2025 . The average WELL Health Technologies target price is CAD7.60. This is higher than the current share price. The highest price target is
CAD10.00 112.31%
register free of charge
, the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend WELL Health Technologies to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the WELL Health Technologies share has an average upside potential 2025 of . Most analysts recommend the WELL Health Technologies share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million CAD 776.05 973.27
36.35% 25.41%
EBITDA margin 13.13% 13.10%
8.52% 0.21%
Net margin 0.00% 0.83%
100.00%

15 Analysts have issued a sales forecast WELL Health Technologies 2024 . The average WELL Health Technologies sales estimate is

CAD973m
unlock
. This is
16.12% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
CAD987m 17.75%
unlock
, the lowest is
CAD962m 14.81%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 CAD776m 36.35%
2024
CAD973m 25.41%
unlock
2025
CAD1.1b 9.93%
unlock
2026
CAD1.2b 8.14%
unlock
2027
CAD1.2b 3.23%
unlock
2028
CAD1.4b 13.91%
unlock

14 Analysts have issued an WELL Health Technologies EBITDA forecast 2024. The average WELL Health Technologies EBITDA estimate is

CAD127m
unlock
. This is
18.25% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD129m 19.86%
unlock
, the lowest is
CAD126m 16.62%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 CAD102m 24.73%
2024
CAD127m 25.11%
unlock
2025
CAD149m 17.02%
unlock
2026
CAD147m 1.18%
unlock
2027
CAD152m 3.05%
unlock

EBITDA margin

2023 13.13% 8.52%
2024
13.10% 0.21%
unlock
2025
13.94% 6.41%
unlock
2026
12.74% 8.61%
unlock
2027
12.72% 0.16%
unlock

7 WELL Health Technologies Analysts have issued a net profit forecast 2024. The average WELL Health Technologies net profit estimate is

CAD8.1m
unlock
. This is
72.62% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD27.0m 8.33%
unlock
, the lowest is
CAD-31.9m 208.33%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 CAD0.0 100.00%
2025
CAD16.0m 97.89%
unlock
2026
CAD86.0m 438.32%
unlock

Net margin

2023 0.00% 100.00%
2025
1.49% 79.52%
unlock
2026
7.43% 398.66%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share CAD 0.00 0.03
100.00%
P/E ratio 143.35
EV/Sales 1.66

7 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies <a href=/blog/eps>EPS is

CAD0.03
unlock
. This is
75.00% lower
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
CAD0.11 8.33%
unlock
, the lowest is
CAD-0.13 208.33%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 CAD0.00 100.00%
2025
CAD0.07 133.33%
unlock
2026
CAD0.35 400.00%
unlock

P/E ratio

Current 38.83 116.08%
2024
143.35 269.17%
unlock
2025
72.46 49.45%
unlock
2026
13.46 81.42%
unlock

Based on analysts' sales estimates for 2024, the WELL Health Technologies share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.93 22.80%
2024
1.66 13.79%
unlock
2025
1.51 9.03%
unlock
2026
1.40 7.53%
unlock
2027
1.36 3.13%
unlock
2028
1.19 12.21%
unlock

P/S ratio

Current 1.38 24.77%
2024
1.19 13.88%
unlock
2025
1.08 9.03%
unlock
2026
1.00 7.52%
unlock
2027
0.97 3.13%
unlock
2028
0.85 12.22%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now